N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride, 97%, 100mg

2-phenyl-1,2,3,4-tetrahydroquinoline, 95%, 250mg

4-(4,5-Dihydro-1,3-oxazol-2-yl)aniline, 250mg

(2-Chloro-5-methylphenyl)hydrazine hydrochloride, 97.0%, 10g

Flacon compte-gouttes avec pipette Verre marron, 50 ml, 10 Pièce(s)

Ethyl 2-Bromoisovalerate>98.0%(GC)5g

5-Amino-N-(4-chlorophenyl)-2-(piperidin-1-yl)benzene-1-sulfonamide, 97%, 250mg

ethyl 3-(difluoromethyl)-1H-pyrazole-5-carboxylate, 95.0%, 2g

Symbole d'avertissement Étiquette individuelle testée sur le terrain, Atmosphère explosive, Longueur de côté 100 mm, 1 pièce

2-Bromo-6-methoxypyridin-4-amine, 95.0%, 10g

2-Bromo-4-(1,1-difluoroethyl)-1-fluorobenzene, 95.0%, 250mg

tert-Butyldichloro(phenyl)silane>95.0%(GC)1g

N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide, 1mg